Linde Other Non-Current Liabilities increased by 152.0% to $10.97B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.6%, from $11.15B to $10.97B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows a downward trend with a -4.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $12.46B | $12.16B | $4.19B | $11.04B | $10.37B | $9.72B | $2.80B | $9.44B | $9.39B | $10.20B | $3.80B | $10.50B | $10.23B | $10.42B | $4.02B | $11.15B | $11.68B | $11.12B | $4.36B | $10.97B |
| QoQ Change | — | -2.4% | -65.6% | +163.6% | -6.0% | -6.3% | -71.2% | +237.9% | -0.6% | +8.6% | -62.7% | +176.1% | -2.6% | +1.9% | -61.5% | +177.7% | +4.7% | -4.7% | -60.8% | +152.0% |
| YoY Change | — | — | — | — | -16.7% | -20.1% | -33.3% | -14.5% | -9.5% | +4.9% | +36.1% | +11.2% | +8.9% | +2.2% | +5.5% | +6.2% | +14.2% | +6.8% | +8.5% | -1.6% |